Ventilator-associated pneumonia: caveats for benchmarking

Détails

ID Serval
serval:BIB_B5A6756C9841
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Ventilator-associated pneumonia: caveats for benchmarking
Périodique
Intensive Care Medicine
Auteur⸱e⸱s
Eggimann  P., Hugonnet  S., Sax  H., Touveneau  S., Chevrolet  J. C., Pittet  D.
ISSN
0342-4642 (Print)
Statut éditorial
Publié
Date de publication
11/2003
Volume
29
Numéro
11
Pages
2086-9
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Nov
Résumé
OBJECTIVE: To determine the influence of using different denominators on risk estimates of ventilator-associated pneumonia (VAP). DESIGN AND SETTING: Prospective cohort study in the medical ICU of a large teaching hospital. PATIENTS: All consecutive patients admitted for more than 48 h between October 1995 and November 1997. MEASUREMENTS AND RESULTS: We recorded all ICU-acquired infections using modified CDC criteria. VAP rates were reported per 1,000 patient-days, patient-days at risk, ventilator-days, and ventilator-days at risk. Of the 1,068 patients admitted, VAP developed in 106 (23.5%) of those mechanically ventilated. The incidence of the first episode of VAP was 22.8 per 1,000 patient-days (95% CI 18.7-27.6), 29.6 per 1,000 patient-days at risk (24.2-35.8), 35.7 per 1,000 ventilator-days (29.2-43.2), and 44.0 per 1,000 ventilator-days at risk (36.0-53.2). When considering all episodes of VAP (n=127), infection rates were 27.3 episodes per 1,000 ICU patient-days (95% CI 22.6-32.1) and 42.8 episodes per 1,000 ventilator-days (35.3-50.2). CONCLUSIONS: The method of reporting VAP rates has a significant impact on risk estimates. Accordingly, clinicians and hospital management in charge of patient-care policies should be aware of how to read and compare nosocomial infection rates.
Mots-clé
Adolescent Adult Aged Aged, 80 and over *Benchmarking Critical Care/methods/standards Cross Infection/diagnosis/*epidemiology/etiology/prevention & control Female Hospital Mortality Hospitals, University Humans Incidence Infection Control/methods/standards Intensive Care Units Length of Stay/statistics & numerical data Male Middle Aged Pneumonia/diagnosis/*epidemiology/etiology/prevention & control Prospective Studies Respiration, Artificial/*adverse effects Risk Assessment Risk Factors Switzerland/epidemiology Time Factors
Pubmed
Web of science
Création de la notice
24/01/2008 17:57
Dernière modification de la notice
20/08/2019 16:24
Données d'usage